Literature DB >> 11435864

High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer.

Y Furuya1, S Cho, S Ohta, N Sato, T Kotake, M Masai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11435864

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells.

Authors:  Yi-Chiu Kuo; Cheng-Fu Kuo; Kurt Jenkins; Alfur Fu-Hsin Hung; Wen-Chung Chang; Miso Park; Brenda Aguilar; Renate Starr; Jonathan Hibbard; Christine Brown; John C Williams
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Metastatic prostate cancer with normal level of serum prostate-specific antigen.

Authors:  R Nishio; Y Furuya; O Nagakawa; H Fuse
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 3.  The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.

Authors:  Andrew N Hoofnagle; Mark H Wener
Journal:  J Immunol Methods       Date:  2009-06-16       Impact factor: 2.303

4.  Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate.

Authors:  Lilie L Lin; Rosemarie Mick; Jeffrey Ware; James Metz; Robert Lustig; Neha Vapiwala; Ramesh Rengan; Ann R Kennedy
Journal:  Oncol Lett       Date:  2014-02-05       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.